Virtu Financial’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$349K Buy
+167,156
New +$329K 0.01% 671
2026
Q1
Sell
-11,870
Closed -$28K 2134
2025
Q4
$28K Buy
+11,870
New +$22.8K ﹤0.01% 1373
2025
Q2
Sell
-15,255
Closed -$10K 1898
2025
Q1
$10K Buy
+15,255
New +$18K ﹤0.01% 1181
2024
Q1
Sell
-3,462
Closed -$31K 1914
2023
Q4
$31K Buy
+3,462
New +$30.3K ﹤0.01% 1250
2023
Q1
Sell
-1,364
Closed -$106K 1945
2022
Q4
$106K Buy
1,364
+1,218
+834% +$70.6K 0.01% 940
2022
Q3
$11K Buy
+146
New +$30.9K ﹤0.01% 1508
2021
Q4
Sell
-23
Closed -$47K 2057
2021
Q3
$47K Sell
23
-1
-4% -$2.21K ﹤0.01% 1285
2021
Q2
$74K Sell
24
-6
-20% -$27.2K 0.01% 1267
2021
Q1
$226K Buy
30
+3
+11% +$20.3K 0.02% 1007
2020
Q4
$109K Buy
27
+21
+350% +$63K 0.01% 1034
2020
Q3
$17K Sell
6
-1
-14% -$3.19K ﹤0.01% 934
2020
Q2
$23K Buy
+7
New +$25.3K ﹤0.01% 1121
2019
Q2
Hold
0
-$15K 1744
2019
Q1
Hold
0
1311
2018
Q4
Hold
0
-$26K 1872
2018
Q3
Hold
0
1381
2018
Q2
Hold
0
1846
2017
Q4
Sell
-1
Closed -$80K 2818
2017
Q3
$80K Buy
+1
New +$209K ﹤0.01% 2123

Other funds holding PALI

Virtu Financial's PALI Position: Q2 2026 in Review

Virtu Financial opened a new position in Palisade Bio (PALI) in Q2 2026: 167,156 shares worth $349K. The stake represents 0.01% of the portfolio and ranks #671 among its holdings. This is a return to the name: Virtu Financial previously reported a position in PALI as recently as Q4 2025.

Virtu Financial first reported a position in PALI in Q3 2017 and has held it in 13 quarters since. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Virtu Financial held 167,156 shares of Palisade Bio worth $349K as of Q2 2026.
  • Palisade Bio was a new Virtu Financial position in Q2 2026.
  • Palisade Bio made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #671 holding.
  • Virtu Financial first reported a position in Palisade Bio in Q3 2017 and has held it in 13 quarters since.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.